High variability of TB, HIV, hepatitis C treatment and opioid substitution therapy among prisoners in Germany

Bibliographic Data

ID15375580
AuthorsJana Müller (0000-0002-3225-6268, Robert Koch Institute), Daniel Schmidt (0009-0009-1627-5790, Robert Koch Institute, corresponding author), Christian Kollan (0000-0002-1483-5194, Robert Koch Institute), Marc Lehmann, Viviane Bremer (0000-0003-0158-7053, Robert Koch Institute), Ruth Zimmermann (0000-0003-3635-2692, Robert Koch Institute)
Year2017
Volume17
Issue1
Pages843-843
Publication date2017-10-24
Open AccessYes
TypeARTICLE
VenueBMC Public Health (JOURNAL)
Journal identifiersISSN: 1471-2458 • E-ISSN: 1471-2458
PublisherBioMed Central (PUBLISHER • GB)
DOI10.1186/s12889-017-4840-4
PMID29065873
OpenAlexW2765348415
LanguageEN
Citations received2
References cited32

According to our findings treatment rates for TB were consistent with the expected TB prevalence, at least in Berlin. HIV treatment seems to be offered to an adequate proportion of estimated infected prisoners. In contrast, the HCV treatment prevalence was low. High variation among FS in provision of all treatments, particularly of OST, point to inconsistent treatment practices, although nationwide extramural treatment guidelines for Germany exist

Biostatistics · Family medicine · Hepatitis C · Public health · Tuberculosis · Criminal Justice and Corrections Analysis · HIV, Drug Use, Sexual Risk · Homelessness and Social Issues · Medicine · Epidemiology · Internal Medicine · Pharmacy

Tools

Open DOISci-HubOpen Access